Market Analysis and Insights: Global Real World Evidence Solutions Market
Real World Evidence is a worldwide trend in Health and Life Sciences. New kinds of data, such as electronic health records and data mining tools are now available and allow us to extract information and knowledge. We can detect medical treatment costs, treatment efficiency (cost, benefits, and risks), references to drugs, side effects, or long-term results.
The global Real World Evidence Solutions market size is projected to reach US$ 1989.7 million by 2028, from US$ 888.4 million in 2021, at a CAGR of 12.0% during 2022-2028.
In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Real World Evidence Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Real World Evidence Solutions market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Real World Evidence Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Real World Evidence Solutions market.
Global Real World Evidence Solutions Scope and Market Size
Real World Evidence Solutions market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Real World Evidence Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
Segment by Application
Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Iqvia
IBM
Pharmaceutical Product Development
Parexel
United Health Group
Perkinelmer
Icon
Oracle
Cognizant
Syneos Health
Anthem
Clinigen
SAS Institute